The Food and Drug Administration has suspended its plan to cut half its laboratories until a new Cabinet-level panel finishes its review of ways to ensure the safety of imports, according to the agency’s Commissioner Andrew C. von Eschenbach.
The suspension will allow officials to "step back, analyze and assess" the results of the high-level review, Dr. von Eschenbach told reporters.
The FDA has been under increasing fire as concerns rise over tainted food and drug imports from China and elsewhere.
President Bush last month set up a panel to examine import safety, headed by Health and Human Services Secretary Michael O. Leavitt that will report back to Mr. Bush next month.
A reorganization plan that would involve cutting seven of the FDA's 13 field laboratories has been criticized by Reps. John D. Dingell and Bart Stupak, both Michigan Democrats.
Read the full Washington Times story here.
Latest from Quality Assurance & Food Safety
- FDA, CDC Investigate Salmonella Outbreak Linked to Live It Up Dietary Supplement Powder
- USDA FSIS Announces New Deputy Administrator of Field Operations
- ProVeg Incubator Launches Fast-Track to Impact Program for Alt-Protein Startups
- Kerry Releases 2026 Global Taste Charts
- FDA Shares Australia Certificate Requirements for Bivalve Molluscs and Related Products
- FDA Announces Update from CFIA on Certificate Requirements for Certain Meat, Poultry Products
- NIMA Partners Introduces the Next-Generation NIMA Gluten Sensor
- IFT to Host Community Conversation on Dietary Guidelines for Americans, 2025-2030 Report
